Aster DM Healthcare Limited (ASTERDM.NS)
INR 500.3
(1.53%)
INR 500.3
(1.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.11 Billion INR | -64.86% |
| 2022 | 10.61 Billion INR | 7.39% |
| 2021 | 15.83 Billion INR | 35.66% |
| 2020 | 11.52 Billion INR | -9.64% |
| 2019 | 13.06 Billion INR | 42.67% |
| 2018 | 9.21 Billion INR | 26.63% |
| 2017 | 8.09 Billion INR | 117.06% |
| 2016 | 8.01 Billion INR | -29.91% |
| 2015 | 4.85 Billion INR | -11.8% |
| 2014 | 5.41 Billion INR | 13.15% |
| 2013 | 4.55 Billion INR | 70.4% |
| 2012 | 2.72 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.63 Billion INR | 169.97% |
| 2024 Q2 | 2.52 Billion INR | 54.27% |
| 2023 Q2 | 3.78 Billion INR | -2.83% |
| 2023 Q3 | 5.63 Billion INR | 48.89% |
| 2023 Q4 | 1.59 Billion INR | -71.73% |
| 2023 FY | - INR | -64.86% |
| 2023 Q1 | 3.89 Billion INR | -25.13% |
| 2022 Q1 | 3.28 Billion INR | -31.53% |
| 2022 Q2 | 3.37 Billion INR | 2.5% |
| 2022 Q3 | 4.58 Billion INR | 35.87% |
| 2022 FY | - INR | 7.39% |
| 2022 Q4 | 5.2 Billion INR | 13.57% |
| 2021 FY | - INR | 35.66% |
| 2021 Q4 | 4.8 Billion INR | 17.43% |
| 2021 Q3 | 4.09 Billion INR | 15.93% |
| 2021 Q2 | 3.52 Billion INR | 21.73% |
| 2021 Q1 | 2.89 Billion INR | -20.35% |
| 2020 Q3 | 3.34 Billion INR | 19.51% |
| 2020 Q2 | 2.8 Billion INR | 86.34% |
| 2020 Q1 | 1.5 Billion INR | -60.94% |
| 2020 FY | - INR | -9.64% |
| 2020 Q4 | 3.64 Billion INR | 8.77% |
| 2019 Q3 | 3.89 Billion INR | 56.19% |
| 2019 Q2 | 2.49 Billion INR | 10.26% |
| 2019 FY | - INR | 42.67% |
| 2019 Q1 | 2.26 Billion INR | -32.7% |
| 2019 Q4 | 3.84 Billion INR | -1.16% |
| 2018 Q1 | 1.45 Billion INR | -46.52% |
| 2018 FY | - INR | 26.63% |
| 2018 Q4 | 3.35 Billion INR | 26.64% |
| 2018 Q3 | 2.65 Billion INR | 88.23% |
| 2018 Q2 | 1.4 Billion INR | -3.39% |
| 2017 Q3 | 1.91 Billion INR | 29.4% |
| 2017 Q1 | 490 Million INR | 0.0% |
| 2017 FY | - INR | 117.06% |
| 2017 Q4 | 2.72 Billion INR | 42.67% |
| 2017 Q2 | 1.47 Billion INR | 201.43% |
| 2016 FY | - INR | -29.91% |
| 2015 FY | - INR | -11.8% |
| 2014 FY | - INR | 13.15% |
| 2013 FY | - INR | 70.4% |
| 2012 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 24.02 Billion INR | 74.539% |
| Artemis Medicare Services Limited | 1.24 Billion INR | -390.844% |
| Fortis Healthcare Limited | 13.07 Billion INR | 53.224% |
| HealthCare Global Enterprises Limited | 3.5 Billion INR | -74.518% |
| Indraprastha Medical Corporation Limited | 2.1 Billion INR | -190.878% |
| Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | 7.482% |
| Lotus Eye Hospital and Institute Limited | 79.42 Million INR | -7600.065% |
| Max Healthcare Institute Limited | 16.7 Billion INR | 63.383% |
| Max India Limited | -353.8 Million INR | 1828.566% |
| Global Health Limited | 8.71 Billion INR | 29.851% |
| Narayana Hrudayalaya Limited | 12.42 Billion INR | 50.78% |
| Rainbow Children's Medicare Limited | 4.69 Billion INR | -30.281% |
| Shalby Limited | 1.98 Billion INR | -208.796% |